The Enterprise Value as of December 2025 (TTM) for Caliway Biopharmaceuticals Co., Ltd. (6919.TWO) is 18.05B

According to Caliway Biopharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 18.05B. This represents a change of -94.06% compared to the average of 304.17B of the last 4 quarters.

Caliway Biopharmaceuticals Co., Ltd. (6919.TWO) Historical Enterprise Value (quarterly & annually)

How has 6919.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Caliway Biopharmaceuticals Co., Ltd. over the last ten years is 127.44B. The current 18.05B Enterprise Value has changed 1.32% with respect to the historical average. Over the past ten years (40 quarters), 6919.TWO's Enterprise Value was at its highest in in the December 2024 quarter at 739.21B. The Enterprise Value was at its lowest in in the December 2022 quarter at 14.33B.

Caliway Biopharmaceuticals Co., Ltd. (6919.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Caliway Biopharmaceuticals Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Caliway Biopharmaceuticals Co., Ltd. (6919.TWO) Average Enterprise Value

How has 6919.TWO Enterprise Value performed in the past?

The current Enterprise Value of Caliway Biopharmaceuticals Co., Ltd. (6919.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Caliway Biopharmaceuticals Co., Ltd. (6919.TWO) Enterprise Value vs. Peers

How is 6919.TWO’s Enterprise Value compared to its peers?

Caliway Biopharmaceuticals Co., Ltd.’s Enterprise Value is less than Pell Bio-Med Technology Co., Ltd. (21.53B), less than Sunmax Biotechnology Co., Ltd. (20.32B), less than Lin BioScience, Inc. (32.77B), less than EirGenix Inc. (20.70B), greater than TaiMed Biologics Inc. (17.67B), less than Polaris Group (24.32B), less than Center Laboratories, Inc. (32.33B), greater than Tanvex BioPharma, Inc. (16.48B), less than Oneness Biotech Co., Ltd. (25.54B), less than TTY Biopharm Company Limited (20.41B),

Build a custom stock screener for Caliway Biopharmaceuticals Co., Ltd. (6919.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Caliway Biopharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Caliway Biopharmaceuticals Co., Ltd. (6919.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Caliway Biopharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.